Diving Deep Into Cell Therapy: An Industry Perspective
Active cell therapy drugs represent the latest in cancer treatment. Of these, chimeric antigen receptor (CAR) cell modalities are considered the most successful.
Sensitive validation and characterization assays are essential for new CAR cell therapies to enter clinical pipelines. Hence, high-quality assay reagents can help scientists to ensure that new therapies are both safe and effective.
Download this whitepaper to learn more about:
- Robust and reproducible methods for CAR expression detection
- Choosing the best reagents for your assay requirements
- Next-generation CAR constructs and the future of cancer treatment